DK1158990T3 - Anvendelse af E5564 til behandlingen af sepsis ved intravenös infusion - Google Patents

Anvendelse af E5564 til behandlingen af sepsis ved intravenös infusion

Info

Publication number
DK1158990T3
DK1158990T3 DK00904375T DK00904375T DK1158990T3 DK 1158990 T3 DK1158990 T3 DK 1158990T3 DK 00904375 T DK00904375 T DK 00904375T DK 00904375 T DK00904375 T DK 00904375T DK 1158990 T3 DK1158990 T3 DK 1158990T3
Authority
DK
Denmark
Prior art keywords
sepsis
intravenous infusion
treatment
methods
endotoxemia
Prior art date
Application number
DK00904375T
Other languages
Danish (da)
English (en)
Inventor
Daniel P Rossignol
Melvyn Lynn
William D Kerns
Original Assignee
Eisai R&D Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Man Co Ltd filed Critical Eisai R&D Man Co Ltd
Application granted granted Critical
Publication of DK1158990T3 publication Critical patent/DK1158990T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/739—Lipopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK00904375T 1999-01-14 2000-01-14 Anvendelse af E5564 til behandlingen af sepsis ved intravenös infusion DK1158990T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11620299P 1999-01-14 1999-01-14
PCT/US2000/001043 WO2000041703A1 (fr) 1999-01-14 2000-01-14 Administration d'un medicament anti-endotoxine par perfusion intraveineuse

Publications (1)

Publication Number Publication Date
DK1158990T3 true DK1158990T3 (da) 2008-01-28

Family

ID=22365882

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00904375T DK1158990T3 (da) 1999-01-14 2000-01-14 Anvendelse af E5564 til behandlingen af sepsis ved intravenös infusion

Country Status (11)

Country Link
EP (3) EP1867336B1 (fr)
JP (1) JP2002534471A (fr)
AT (2) ATE375798T1 (fr)
AU (1) AU2614400A (fr)
CA (1) CA2359478A1 (fr)
CY (1) CY1108039T1 (fr)
DE (2) DE60045750D1 (fr)
DK (1) DK1158990T3 (fr)
ES (1) ES2291188T3 (fr)
PT (1) PT1158990E (fr)
WO (1) WO2000041703A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004503472A (ja) * 2000-06-09 2004-02-05 エーザイ株式会社 ボーラスまたは間欠的な静脈内注入による、抗内毒素薬の投与
US20030105033A1 (en) 2000-06-09 2003-06-05 Rossignol Daniel P. Administration of an anti-endotoxin drug by bolus or intermittent intravenous infusion
US7727974B2 (en) 2001-08-10 2010-06-01 Eisai R & D Management Co., Ltd. Methods of reducing the severity of mucositis
WO2003013440A2 (fr) * 2001-08-10 2003-02-20 Eisai Co., Ltd. Traitement et prevention de maladies et de conditions associees a la proteine de choc thermique
JP6778681B2 (ja) 2014-12-12 2020-11-04 ザ ファインスタイン インスティテュート フォー メディカル リサーチ Ｈｍｇｂ１媒介性炎症の治療

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5530113A (en) 1991-10-11 1996-06-25 Eisai Co., Ltd. Anti-endotoxin compounds
US5750664A (en) * 1995-06-05 1998-05-12 Eisai Co., Ltd. Substituted liposaccharides useful in the treatment and prevention of endotoxemia

Also Published As

Publication number Publication date
EP2298326A3 (fr) 2011-04-27
DE60045750D1 (de) 2011-04-28
DE60036790D1 (de) 2007-11-29
ATE501760T1 (de) 2011-04-15
EP1867336A2 (fr) 2007-12-19
WO2000041703A1 (fr) 2000-07-20
JP2002534471A (ja) 2002-10-15
EP1867336A3 (fr) 2008-04-23
ES2291188T3 (es) 2008-03-01
CA2359478A1 (fr) 2000-07-20
EP2298326A2 (fr) 2011-03-23
EP1158990A4 (fr) 2003-08-13
DE60036790T2 (de) 2008-07-24
ATE375798T1 (de) 2007-11-15
EP1867336B1 (fr) 2011-03-16
EP1158990A1 (fr) 2001-12-05
EP1158990B1 (fr) 2007-10-17
CY1108039T1 (el) 2013-09-04
AU2614400A (en) 2000-08-01
PT1158990E (pt) 2007-12-21

Similar Documents

Publication Publication Date Title
FR12C0004I1 (fr)
EA200601552A1 (ru) Замещенные конденсированные гетероциклические с-гликозиды
ATE246197T1 (de) Neue heteroaromatische fructose 1,6- bisphosphatase inhibitoren
DK0842934T3 (da) 5-HT1F agonister
EA200601555A1 (ru) Замещенные индазол-о-глюкозиды
EA200601554A1 (ru) Замещенные индол-о-глюкозиды
IS6195A (is) Notkun á mótefnum gegn CD20 til meðhöndlunar á þegahöfnunarveiki
EA200100411A1 (ru) Замещенные 3-цианохинолины в качестве ингибиторов протеинтирозинкиназ
DK0966447T3 (da) Anvendelige små molekyler til behandling af betændelsessygdomme
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
HK1088002A1 (en) Process for resolving 2,4-diamino-3,6-dihydro-1,3,5-triazines, useful for the treatment of disordersassociated with insulin resistance syndrome
EA200200790A1 (ru) Аминированные производные дигидро-1,3,5-триазина и их применение в терапии
ATE350385T1 (de) Neue aryl fructose-1,6-bisphosphatase inhibitoren
BR0106411B1 (pt) processo de tratamento do lìquido residual de cromatização.
DK1183269T3 (da) Svækkede mikroorganismer til behandlingen af infektion
CY1108039T1 (el) Χρηση e5564 για την θεραπεια σηψαιμιας με ενδοφλεβια εγχυση
TR200001290T2 (tr) Estrojen mahrumiyet sendromunu tedavi etmek için yararlı 2-aril-3-aroilbenzo(b) tiofenler.
ID25478A (id) Agonis 5-ht1f
ITGE20020050A0 (it) Procedimento per il trattamento di filati mediante agugliatura.
WO2001010384A3 (fr) Methode d'identification de composes destines au traitement de la resistance a l'insuline
WO2001093921A3 (fr) Administration d'un medicament anti-endotoxine par injection d'un bol ou par perfusion intraveineuse intermittente
ITRM920305A0 (it) Composizione farmaceutica per il trattamento dello shock, particolarmente dello shock cardiogeno e dello shock settico.
ATE257822T1 (de) Aminoiminochinon und aminochinon alkaloid verbindungen als caspase inhibitoren
EA199800822A1 (ru) Способ лечения избыточной агрессии
ATE294167T1 (de) Chemische verbindungen